Back to top
more

Sabra Healthcare REIT (SBRA)

(Delayed Data from NSDQ)

$18.41 USD

18.41
3,057,108

+0.12 (0.66%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $18.44 +0.03 (0.16%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 246)

Industry: REIT and Equity Trust - Other

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Sabra (SBRA) Stock Jumps 5.5%: Will It Continue to Soar?

by Zacks Equity Research

Sabra (SBRA) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might help the stock continue moving higher in the near term.

Zacks Equity Research

Sabra Healthcare (SBRA) Surpasses Q2 FFO Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 5.41% and 2.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sabra Healthcare (SBRA) Q1 FFO and Revenues Beat Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 2.63% and 1.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Easterly Government Properties (DEA) Lags Q1 FFO and Revenue Estimates

by Zacks Equity Research

Easterly Government Properties (DEA) delivered FFO and revenue surprises of -2.94% and 3.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sabra Healthcare (SBRA) Surpasses Q4 FFO Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 2.78% and 11.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Franklin Street Properties (FSP) Lags Q4 FFO and Revenue Estimates

by Zacks Equity Research

Franklin Street (FSP) delivered FFO and revenue surprises of -16.67% and 2.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Down 12.8% in 4 Weeks, Here's Why Sabra (SBRA) Looks Ripe for a Turnaround

by Zacks Equity Research

Sabra (SBRA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

Sabra Healthcare (SBRA) Q3 FFO Meet Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 0.00% and -9.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Vedika Agarwal headshot

Is Sabra Healthcare (SBRA) a Great Stock for Value Investors?

by Vedika Agarwal

Let's see if Sabra Healthcare (SBRA) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Equity Research

Sabra Healthcare (SBRA) Q2 FFO Surpass Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 2.63% and -0.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

New Strong Sell Stocks for June 11th

by Zacks Equity Research

BLIN, BNR, MOV, BAP and SBRA have been added to the Zacks Rank #5 (Strong Sell) List on June 11, 2021.

Zacks Equity Research

New Strong Sell Stocks for April 1st

by Zacks Equity Research

ALE, FLR, SBRA, WRE, and WELL have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2021

Zacks Equity Research

Should You Buy Sabra (SBRA) Ahead of Earnings?

by Zacks Equity Research

Sabra (SBRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

Sabra Healthcare (SBRA) Beats Q3 FFO Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 9.52% and -6.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Here's Why You Should Retain Iron Mountain (IRM) Stock Now

by Zacks Equity Research

While Iron Mountain's (IRM) efforts to expand its data-center portfolio will diversify its revenue mix, there has been a slowdown in its service business due to the pandemic-related shutdowns.

Zacks Equity Research

SL Green (SLG) Inks Long-Term Lease at One Vanderbilt Avenue

by Zacks Equity Research

SL Green (SLG) is witnessing a decent leasing momentum at its iconic skyscraper One Vanderbilt Avenue. The property, opened in mid-September, is around 70% leased.

Zacks Equity Research

Welltower's (WELL) Liquidity Improves, Occupancy Declines

by Zacks Equity Research

While asset sales will improve Welltower's (WELL) near-term liquidity amid these testing times, the challenging operating environment for senior housing is driving occupancy loss.

Zacks Equity Research

Plymouth Increases Credit Facility, Lowers Cost of Debt

by Zacks Equity Research

Plymouth (PLYM) extends and expands its credit facilities by $100 million. Moreover, the new unsecured credit facilities will result in lower interest expenses.

Zacks Equity Research

Equinix Launches Oman Facility, Unveils Bare Metal Service

by Zacks Equity Research

Equinix (EQIX) expands its footprint with a new data center in Oman. It also unveils a bare-metal service, Equinix Metal, offering a deployment method for customers' digital infrastructures.

Zacks Equity Research

Simon Property, Afterpay Team Up as Holiday Season Approaches

by Zacks Equity Research

Simon Property's (SPG) alliance with Afterpay is likely to benefit retail tenants of the former by luring new customers and boosting sales on the attractive payment options.

Zacks Equity Research

SL Green (SLG) Tops Off 34 Floors of 185 Broadway Property

by Zacks Equity Research

SL Green's (SLG) development project, 185 Broadway, will be the region's first affordable housing development to be built through the Affordable New York Housing Program.

Zacks Equity Research

Welltower Continues Dispositions, Announces $1.3B of Sales

by Zacks Equity Research

Welltower's (WELL) dispositions of $1.3 billion indicate strong demand for its high-quality assets and the revival of the senior housing transaction market despite the pandemic-led challenges.

Zacks Equity Research

Here's Why Prologis is a Promising Investment Bet Right Now

by Zacks Equity Research

Prologis (PLD) stock is an attractive investment option at the moment given its solid prospects and healthy operating performance.

Zacks Equity Research

Alpine Income on Acquisition Spree, Adds 2 Retail Properties

by Zacks Equity Research

Alpine Income's (PINE) recently acquired single-tenant net leased properties, with investment-grade tenant and long lease term, will enable it to enjoy stable revenues in the upcoming period.

Zacks Equity Research

Here's Why You Should Hold on to Healthpeak (PEAK) Stock Now

by Zacks Equity Research

Healthpeak's (PEAK) life science properties are benefiting from the robust demand for space amid increasing need to develop coronavirus vaccines. Yet, soft senior housing environment remains a woe.